June 30, 2004 - New drug to prevent lasting brain damage

Pharmos is focused on helping people think more clearly -- with cannabis. The biotechnology company is developing cannabis-related compounds that don't have psychotropic effects as potential treatments for central nervous system disorders. Pharmos' lead drug candidate, dexanabinol, is a neuroprotective compound that could prevent lasting damage from traumatic brain injury. It has received FDA fast track status for this indication. The drug candidate may also limit post-surgery memory loss and cognitive impairment. Other targets for these compounds include stroke, neuropathic pain, multiple sclerosis, and Alzheimer's disease.

Bledsoe Law Office
408 Wood Avenue
Big Stone Gap, VA, 24219

Jonesville, VA
No. 2 Church Street*
Jonesville, Virginia 24263
(276) 346-3690

Bristol, TN
1619 Highway 11W
Bristol, Tennessee 37620
(423) 764-0322

See our Contact Us page for detailed map to each office